These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8282035)

  • 21. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts.
    Packer L
    Ann N Y Acad Sci; 1994 Nov; 738():257-64. PubMed ID: 7832436
    [No Abstract]   [Full Text] [Related]  

  • 23. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
    Romero FJ; Sies H
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked reduction of rat brain glutathione following intracerebroventricular administration of the glutathione synthesis inhibitor L-buthionine sulfoximine.
    Pileblad E; Magnusson T
    Neurosci Lett; 1988 Dec; 95(1-3):302-6. PubMed ID: 3226616
    [No Abstract]   [Full Text] [Related]  

  • 25. A light and electron microscopic study of anterior subcapsular cataracts.
    Font RL; Brownstein S
    Am J Ophthalmol; 1974 Dec; 78(6):972-84. PubMed ID: 4140696
    [No Abstract]   [Full Text] [Related]  

  • 26. Glutathione depletion in tissues after administration of buthionine sulphoximine.
    Minchinton AI; Rojas A; Smith KA; Soranson JA; Shrieve DC; Jones NR; Bremner JC
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural changes during the development and reversal of galactose cataracts.
    Unakar NJ; Genyea C; Reddan JR; Reddy VN
    Exp Eye Res; 1978 Feb; 26(2):123-33. PubMed ID: 631228
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione is required for intestinal function.
    Mårtensson J; Jain A; Meister A
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1715-9. PubMed ID: 2308931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An electron microscopic study of the lens epithelium in a mouse strain with hereditary cataract.
    Hamai Y
    Nippon Ganka Gakkai Zasshi; 1976 Sep; 80(9):717-28. PubMed ID: 1035036
    [No Abstract]   [Full Text] [Related]  

  • 31. Glutathione levels in cultured heart cells. Influence of buthionine sulfoximine, an inhibitor of glutathione synthesis.
    Lewko WM
    Biochem Pharmacol; 1987 Jan; 36(2):219-23. PubMed ID: 3814167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
    Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
    Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione metabolism in the lung: inhibition of its synthesis leads to lamellar body and mitochondrial defects.
    Mårtensson J; Jain A; Frayer W; Meister A
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5296-300. PubMed ID: 2748585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depletion of brain glutathione in preweanling mice by L-buthionine sulfoximine.
    Slivka A; Spina MB; Calvin HI; Cohen G
    J Neurochem; 1988 May; 50(5):1391-3. PubMed ID: 3361302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thioredoxin reductase activity may be more important than GSH level in protecting human lens epithelial cells against UVA light.
    Padgaonkar VA; Leverenz VR; Bhat AV; Pelliccia SE; Giblin FJ
    Photochem Photobiol; 2015; 91(2):387-96. PubMed ID: 25495870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
    Campbell EB; Hayward ML; Griffith OW
    Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echothiophate cataracts in monkeys. Electron microscopy and microradiography.
    Philipson B; Kaufman PL; Fagerholm P; Axelsson U; Bárány EH
    Arch Ophthalmol; 1979 Feb; 97(2):340-6. PubMed ID: 121693
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of systemic glutathione depletion by buthionine sulfoximine on sensitivity of murine bladder cancer to cytotoxic agents.
    Lee KE; Mayer RD; Cockett AT
    Urology; 1989 Dec; 34(6):376-80. PubMed ID: 2595883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxic effects of extended glutathione depletion by buthionine sulfoximine on murine mammary carcinoma cells.
    Dethlefsen LA; Biaglow JE; Peck VM; Ridinger DN
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1157-60. PubMed ID: 3744934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous cataract in nude athymic mice: ultrastructural analysis.
    Hazlett LD; Bradley RH
    Exp Eye Res; 1978 Feb; 26(2):207-17. PubMed ID: 631234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.